$4.20+0.17 (+4.22%)
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.
Universe Pharmaceuticals INC in the Healthcare sector is trading at $4.20 with a market capitalization of $21M. The stock is currently near its 52-week low of $2.00, remaining 10.5% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 |
|---|---|---|---|---|---|
| Total Revenue | β | β | β | β | β |
| Gross Profit | β | β | β | β | β |
| Operating Income | β | β | β | β | β |
| Net Income | β | β | β | β | β |
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common ...

Universe Pharmaceuticals Inc (NASDAQ:UPC) shares rose 22. 6% to $5.
Universe Pharmaceuticals agreed to buy 100% of Best Praise International Limited, a company that holds five patents in China.